These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction. Vandewalle-El Khoury P; Colombel JF; Joossens S; Standaert-Vitse A; Collot M; Halfvarson J; Ayadi A; Landers CJ; Vermeire S; Rutgeerts P; Targan SR; Chamaillard M; Mallet JM; Sendid B; Poulain D Am J Gastroenterol; 2008 Apr; 103(4):949-57. PubMed ID: 18047546 [TBL] [Abstract][Full Text] [Related]
5. Candida albicans colonization and ASCA in familial Crohn's disease. Standaert-Vitse A; Sendid B; Joossens M; François N; Vandewalle-El Khoury P; Branche J; Van Kruiningen H; Jouault T; Rutgeerts P; Gower-Rousseau C; Libersa C; Neut C; Broly F; Chamaillard M; Vermeire S; Poulain D; Colombel JF Am J Gastroenterol; 2009 Jul; 104(7):1745-53. PubMed ID: 19471251 [TBL] [Abstract][Full Text] [Related]
6. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007 [TBL] [Abstract][Full Text] [Related]
7. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features. Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117 [TBL] [Abstract][Full Text] [Related]
8. 3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn's disease in Tunisian population. Marrakchi R; Bougatef K; Moussa A; Ouerhani S; Khodjet-el-Khil H; Messai Y; Mestiri O; Najar T; Benammar-Elgaaeid A Inflamm Res; 2009 Apr; 58(4):218-23. PubMed ID: 19184350 [TBL] [Abstract][Full Text] [Related]
9. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease. Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858 [TBL] [Abstract][Full Text] [Related]
10. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689 [TBL] [Abstract][Full Text] [Related]
11. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Standaert-Vitse A; Jouault T; Vandewalle P; Mille C; Seddik M; Sendid B; Mallet JM; Colombel JF; Poulain D Gastroenterology; 2006 May; 130(6):1764-75. PubMed ID: 16697740 [TBL] [Abstract][Full Text] [Related]
12. Low Mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA). Schoepfer AM; Flogerzi B; Seibold-Schmid B; Schaffer T; Kun JF; Pittet V; Mueller S; Seibold F Am J Gastroenterol; 2009 Oct; 104(10):2508-16. PubMed ID: 19532127 [TBL] [Abstract][Full Text] [Related]
13. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases]. Mokrowiecka A; Gasiorowska A; Małecka-Panas E Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542 [TBL] [Abstract][Full Text] [Related]
15. Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment. Teml A; Kratzer V; Schneider B; Lochs H; Norman GL; Gangl A; Vogelsang H; Reinisch W Am J Gastroenterol; 2003 Oct; 98(10):2226-31. PubMed ID: 14572572 [TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases. Bartůnková J; Kolárová I; Sedivá A; Hölzelová E Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458 [TBL] [Abstract][Full Text] [Related]
17. Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania. Preda CM; Diculescu M; Mirea V; Marica C; Vermeire S; Rutgeerts P; Oproiu A Rom J Gastroenterol; 2005 Mar; 14(1):23-6. PubMed ID: 15800689 [TBL] [Abstract][Full Text] [Related]
18. [Interest of serologic markers in inflammatory bowel disease. About 105 cases]. Fekih M; Ben Hlima S; Zitouni M; Matri S; Boubaker J; Makni S; Azza F Tunis Med; 2007 Oct; 85(10):821-8. PubMed ID: 18236802 [TBL] [Abstract][Full Text] [Related]
19. [Initial experience with detection of Saccharomyces cerevisiae antibodies in patients with primary nonspecific inflammatory bowel disease]. Malícková K; Janatková I; Fucíková T; Adamec S; Lukás M Epidemiol Mikrobiol Imunol; 2001 Aug; 50(3):131-5. PubMed ID: 11550421 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course. Kim BC; Park S; Han J; Kim JH; Kim TI; Kim WH Dig Liver Dis; 2007 Jul; 39(7):610-6. PubMed ID: 17531556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]